Current Issues in Pediatric Medication Adherence
- 411 Downloads
With the recent emphasis on investigating the efficacy of medication in children, it is also important to assess what determines whether pediatric patients do or do not take their medication. In general, children are no better at adhering to drug therapy than older individuals. Dealing with medication nonadherence is essential given its association with a failure to achieve the desired treatment goal. In addition to the many factors that influence adherence in adults, there are some unique challenges faced in the pediatric age group including the role of family (and its dysfunction), the changes of adolescence, and the lack of appropriate drug formulations.
Intervention strategies to improve adherence include behavioral and educational strategies. Although there is no consensus as to what is the best approach to promote adherence with therapy, attention should be given to determining what barriers exist and trying to overcome them by involving children and their parents in the treatment planning process. If possible, the medication regimen, taking into account the frequency and timing of administration, should be tailored to the child and family’s lifestyle and daily routine. Consideration should be given to the palatability and formulations of medications prescribed for young children. The use of simplified regimens of better tasting medications and age-appropriate delivery mechanisms may enhance the ability of pediatric patients to adhere to their drug therapy.
KeywordsMedication Adherence Budesonide Familial Hypercholesterolemia Parental Supervision Concerta
No sources of funding were used to assist in the preparation of this review. The author has no conflicts of interest that are directly relevant to the content of this review.
- 4.Burkhart PV, Dunbar-Jacob J. Adherence research in the pediatric and adolescent populations: a decade in review. In: Hayman LL, Mahon MM, Turner JR, editors. Chronic illness in children: an evidence-based approach. New York: Springer Publishing Company, Inc., 2002: 199–229Google Scholar
- 6.World Health Organization. Adherence to long-term therapies: evidence for action [online]. Available from URL: http://www.emro.who.int/ncd/Publications/adherence_report.pdf [Accessed 2006 Nov 13]
- 9.Rudd P, Ahmed S, Zachary V, et al. Compliance with medication timing: implications from a medication trial for drug development and clinical practice. J Clin Res Pharmacoepidemiol 1992; 6: 15–27Google Scholar
- 26.Farley J, Hines S, Musk A, et al. Assessment of adherence to antiviral therapy in HIV-infected children using the medication event monitoring system, pharmacy refill, provider assessment, caregiver self-report, and appointment keeping. J Acquir Immune Defic Syndr 2003; 33: 211–8PubMedCrossRefGoogle Scholar
- 39.Thatcher Shope J. Medication compliance. Pediatr Clin North Am 1981; 28: 5–21Google Scholar
- 43.Staples B, Bravender T. Drug compliance in adolescents assessing and managing modifiable risk factors. Pediatr Drugs 2002; 4: 503–13Google Scholar
- 51.Ramgoolam A, Steele R. Formulations of antibiotics for children in primary care effects on compliance and efficacy. Pediatr Drugs 2002; 4: 323–33Google Scholar
- 67.Tuleu C. An overview of paediatric drug delivery. Drug Deliv Rep 2005 Autumn/Winter [online]. Available from URL: http://www.drugdeliveryreport.com/articles/ddr_W2005_article02.pdf [Accessed 2007 Oct 8]Google Scholar